METHOD OF TREATING MALIGNANCIES IN MAMMALS

摘要

FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to biotechnology, more specifically to using recombinant proteins for treating mammals suffering malignancies. A method of treating involves the injections of an antitumour agent of a protein factor specific to malignant cells. The antitumour agent is presented by a recombinant peptide of molecular weight approximately 16 kDa containing methionine residue, a fragment of human kappa casein of 24 to 134 amino acid residue and C-terminal histidine tract. The agent is introduced intravenously daily in dose 8-100 mg/kg of body weight; the therapeutic course is 2-6 days. ^ EFFECT: invention allows higher effectiveness of antitumour therapy. ^ 5 dwg, 4 ex